help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2008.070572 on May 15, 2008

Published online before print May 15, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2008.070572v1
172/6/1555    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Heikenwalder, M.
Right arrow Articles by Aguzzi, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heikenwalder, M.
Right arrow Articles by Aguzzi, A.
(American Journal of Pathology. 2008;172:1555-1570.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.070572

Overexpression of Lymphotoxin in T Cells Induces Fulminant Thymic Involution

Mathias Heikenwalder*, Marco Prinz*, Nicolas Zeller*, Karl S. Lang{dagger}, Tobias Junt{dagger}, Simona Rossi, Alexei Tumanov{ddagger}, Hauke Schmidt{dagger}{dagger}, Josef Priller{dagger}, Lukas Flatz{dagger}, Thomas Rülicke**, Andrew J. Macpherson§, Georg A. Holländer, Sergei A. Nedospasov{ddagger} and Adriano Aguzzi*

From the Institutes of Neuropathology,* and Experimental Immunology,{dagger} University Hospital of Zürich, Zürich, Switzerland; the Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, and the Belozersky Institute of Physico-Chemical Biology,{ddagger} Moscow State University, Moscow, Russia; the Department of Medicine,§ McMaster University, Hamilton, Ontario, Canada; Pediatric Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland; the Institute of Neuropathology and Neuropsychiatry,|| Laboratory of Molecular Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany, the Institute of Laboratory Animal Science and Research Center Biomodels Austria,** University of Veterinary Medicine, Vienna, Austria; and the Institute for Neuropathology,{dagger}{dagger} the Georg-August-University, Göttingen, Germany

Activated lymphocytes and lymphoid-tissue inducer cells express lymphotoxins (LTs), which are essential for the organogenesis and maintenance of lymphoreticular microenvironments. Here we describe that T-cell-restricted overexpression of LT induces fulminant thymic involution. This phenotype was prevented by ablation of the LT receptors tumor necrosis factor receptor (TNFR) 1 or LT beta receptor (LTβR), representing two non-redundant pathways. Multiple lines of transgenic Lt{alpha}β and Lt{alpha} mice show such a phenotype, which was not observed on overexpression of LTβ alone. Reciprocal bone marrow transfers between LT-overexpressing and receptor-ablated mice show that involution was not due to a T cell-autonomous defect but was triggered by TNFR1 and LTβR signaling to radioresistant stromal cells. Thymic involution was partially prevented by the removal of one allele of LTβR but not of TNFR1, establishing a hierarchy in these signaling events. Infection with the lymphocytic choriomeningitis virus triggered a similar thymic pathology in wt, but not in Tnfr1–/– mice. These mice displayed elevated TNF{alpha} in both thymus and plasma, as well as increased LTs on both CD8+ and CD4CD8 thymocytes. These findings suggest that enhanced T cell-derived LT expression helps to control the physiological size of the thymic stroma and accelerates its involution via TNFR1/LTβR signaling in pathological conditions and possibly also in normal aging.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.